Abstract: Provided herein are multilayer polymeric interlayers comprising ionomers and acoustic damping compositions, and glass laminates made from them, which provide an improved combination of hurricane resistance, acoustic damping properties and, optionally, solar barrier performance.

Abstract: A system for providing a remote computing resource to a user equipment comprises the user equipment and at least one server. The user equipment is configured to receive a user input from an input device of the user equipment and send data identifying the user input to the server, wherein the data identifying the user input is based on data from a hardware driver of the input device. The server is configured to receive the data identifying the user input, cause execution of the remote computing resource based on the data identifying the user input, and send an output of the executed remote computing resource to the user equipment. A user equipment and a server are also provided.

Abstract: A system for monitoring gastro-intestinal disorders including: a gastro-intestinal probe; at least one sensor configured to measure a parameter of the patient; a patient interface configured to receive inputs from the patient; a processor configured to: determine a first and second values corresponding to a given time interval: wherein, if an input from the patient corresponds to the given time interval, the first value is determined based on a measurement of the parameter corresponding to the given time interval and on the input from the patient corresponding to the given time interval, and wherein said second value is determined based on a measurement of gastro-esophageal content corresponding to the given time interval; and determine a level of gastro-intestinal disorder based on the determined set of pairs of values.

Abstract: A system for monitoring Gastro-intestinal disorders including: a gastro-intestinal probe; at least one sensor configured to measure a parameter of the patient; a processor configured to: determine a first and second values corresponding to a given time interval, wherein the first value is determined based on a measurement of the parameter and the second value is determined based on a measurement of gastro-esophageal content corresponding to the given time interval; and determine a level of gastro-intestinal disorder based on the determined set of pairs of values.

Abstract: The invention relates to a nutraceutical formulation of blueberry extract, fish oil (omega-3 and omega-6), recombinant human lactoferrin, vitamin A and vitamin E, for human oral consumption. The invention belongs to the field of ophthalmology and has been developed as a coadjuvant for preserving the health of the precorneal film and of the eye surface. This formulation contains an extract of natural origin (Vaccinium myrtillus L) with antioxidant and anti-inflammatory properties; it also uses eicosapentaenoic acid (EPA), omega-6, and docosahexaenoic acid (DHA), omega-3, obtained from fish oil and which, together with lactoferrin, vitamin A and vitamin E, improves tear quality, since these compounds have anti-microbial and anti-inflammatory effects. This formulation has been designed as a coadjuvant for preserving the health of the precorneal film.

Abstract: A photon source for promoting the growth and maturation rate of members of the Plantae and Protista Kingdoms comprises a new luminous power source that provides the full range of light spectra by mimicking sunlight in a sunfleck (dappled) pattern by exciting xenon gas inside of an enclosed glass tube in instantaneous pulsed sequences. The micro-dose pulse penetrates the leaf strata to reach the maximum amount of photon processing pigments, provides the energy required for growth by enhancing photosynthetic plant functions, and significantly reducing production energy consumption. The pulse also allows the plant or Protista's photon processing compounds to process the photosynthesis reaction before the next flash, which allows for optimal use of the energy provided. The pulsed lighting sequences reduce energy consumption by up to 90%, and this makes it an excellent application for solar, wind or other green energy power thus reducing carbon footprint and making it the future of the CEA industry.

Abstract: A foldable music teaching device is disclosed. The music teaching device includes a plate. The plate includes a first plate, a second plate, and a third plate. The second plate comes in a rectangular configuration and acts as a center plate of the plate. Each of the first plate and the third plate comes in a semi-circular configuration and connects at either side of the second plate. Each of the first plate, the second plate, and the third plate includes zones for receiving magnetic pads. The plate includes legs/supports. The legs/supports help to position the plate at a height from the ground. The second plate presents a hinge plate. The hinge plate allows to position music notes over the second plate such that users stand surrounding the plate. The users view the music notes and use musical instruments to produce sound by hitting the musical instruments over the magnetic pads.

Abstract: A combination in only one dosage unit the drugs desloratadine and betamethasone, which represents a set of important technological challenges due to the physicochemical properties and the difference in dosage to ensure the obtaining of a stable product for the treatment of allergic and inflammatory processes in a subject.

Abstract: An improved, immediate-release pharmaceutical composition against respiratory diseases and acute upper respiratory tract infections (IAVRS) with a stable bioavailability and includes an analgesic, such as ibuprofen; an antihistamine, such as loratadine; and one or more excipients, such as suspending agents, solubilizers, co-solvents, sweeteners or flavorings, colorants, preservatives or antimicrobials, and solvents. The manufacturing process of the composition manages to overcome the technological complexity of having both drugs in liquid form while preserving their physicochemical properties.

Abstract: Pharmaceutical compositions of tramadol and pregabalin, or a pharmaceutically acceptable salt thereof, for the treatment of neuropathic pain. Besides offering an analgesic effect and a decrease of adverse events due to the reduced dose of one or both compounds, it has an improved stability, thus maintaining the dissolution and bioavailability of the composition to be administered. The composition manages to overcome the technological difficulty of having two humidity- and light-sensitive drugs in a dispensing medium that does not affect their absorption by means of a water-free process and a light protection coating without affecting the release of both drugs.

Abstract: The manufacture of fixed-dose combination drug products to be used as an anti-inflammatory and antineuritic agents for the control and management of pain, particularly moderate to severe intensity acute pain of different etiologies resulting from peripheral neuropathies, low back pain, sciatica, neck pain, radiculitis, post-herpetic neuralgia, spondylitis, carpal tunnel syndrome, fibromyalgia, etc., of different etiologies such as inflammatory, drug, diabetic, alcoholic, or nutritional etiology, etc. These fixed-dose combination drug products contain a therapeutically effective amount of (a) a non-steroidal anti-inflammatory drug (NSAID) or a pharmaceutically acceptable salt thereof, (b) an antineuritic agent or a pharmaceutically acceptable salt thereof, and (c) at least one pharmaceutically acceptable amount of a pharmaceutically acceptable excipient.

Abstract: A photon source for promoting the growth and maturation rate of members of the Plantae and Protista Kingdoms comprises a new luminous power source that provides the full range of light spectra by mimicking sunlight in a sunfleck (dappled) pattern by exciting xenon gas inside of an enclosed glass tube in instantaneous pulsed sequences. The micro-dose pulse penetrates the leaf strata to reach the maximum amount of photon processing pigments, provides the energy required for growth by enhancing photosynthetic plant functions, and significantly reducing production energy consumption. The pulse also allows the plant or Protista's photon processing compounds to process the photosynthesis reaction before the next flash, which allows for optimal use of the energy provided. The pulsed lighting sequences reduce energy consumption by up to 90%, and this makes it an excellent application for solar, wind or other green energy power thus reducing carbon footprint and making it the future of the CEA industry.

Abstract: A combination, in a single dosage form, the active principles, atorvastatin and fenofibrate, which represents a set of important technological challenges due to the physicochemical properties and the difference in dosage to ensure obtaining a stable product in the treatment of hyperlipidemia and the prevention of cardiovascular diseases.

Abstract: An innovative stable immediate release drug for the treatment, control, and better management of type 2 diabetes mellitus containing a sulfonylurea such as glimepiride, a dipeptidyl peptidase-4 (DPP4) inhibitor such as vildagliptin, and a biguanidine such as metformin. At the same time, this invention allows solving a set of important technological challenges in the manufacture of said drug product due to the physicochemical properties and the difference in dosage of the synergistic combination of the drugs.

Abstract: The present disclosure relates to a heating, ventilation, and air conditioning (HVAC) system that includes a heat exchanger configured to circulate a working fluid therethrough, a valve configured to regulate a flow rate of the working fluid through the heat exchanger, and a valve controller configured to modify a valve position control signal received from an external controller, separate from the valve controller, based on a temperature differential of the working fluid entering and exiting the heat exchanger.

Abstract: The recited invention is a method of treating patients having macular edema secondary to branch renal vein occlusion. The patients are treated with a liposomal nanoparticle formulation comprising thermodynamically stable liposomes and a steroid such as triamcinolone acetonide. The formulation is a topical ophthalmic formulation administered topically to treat the posterior segment disease.

Abstract: The present invention is related to biotechnology, particularly to the field of human health. It provides new vaccine compositions that comprise as active principle a system that contains the recombinant human EGF, or peptides thereof, and a carrier protein or peptide, bound to a nucleus constituted by inorganic nanoparticles, with nanometric or submicrometric scale dimensions. These vaccine compositions are useful for the chronic treatment of cancer and have as advantages that their administration does not result in the appearance of adverse effects at the injection site and that they do not accumulate in the body.

Abstract: A wind turbine is disclosed which comprises a control system configured to execute at least one ice removal routine which comprises a heating stage of at least one of the blades (3), and a mechanical removal ice stage. A wind turbine removing ice method is also disclosed which comprises a stage wherein the presence of ice is detected on at least one of the blades and, once said presence of ice is detected, comprises a stage wherein at least one ice removal routine is activated which comprises, in turn, a heating stage of at least one of the blades and a mechanical removing ice stage on at least said blade.

Abstract: An actuator includes a motor, a drive member coupled to the motor and structured to transfer movement from the motor to an external mechanism, and a control chip configured to host a web server, connect with a wireless communication network and provide access to the web server via the wireless communication network, and control the motor using reprogrammable control logic. The reprogrammable control logic is adjustable by a user via the web server and the wireless communication network.

Abstract: A prosthetic device can be implanted in the corpora cavernosa of a penis with erectile dysfunction. The device being formed by two cylinders that can be inflated with a fluid. The device comprises a variable-length erectable portion formed by a chamber that can be pressurized with a low volume of fluid and is formed between an expandable membrane and an axially extendable and foldable longitudinal rib. The membrane and rib extend between a distal tip element and an intermediate connector from which a shortenable anchoring rod emerges, the rib being a single piece formed by a variable-length distal section, an intermediate section that is foldable and extendable in an axial direction, and a proximal section comprising optimized means for the continuous lateral supply of the fluid to the pressurisable chamber. The device also has an integrated unit for storing and pressurizing the fluid, which can be implanted in the scrotum.